RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Roche Holding AG

A collection of news and information related to Roche Holding AG published by this site and its partners.

Top Roche Holding AG Articles see all

Displaying items 1-5
  • Regeneron says allergy drug may be darling of its pipeline

    (Reuters) - Regeneron Pharmaceuticals Inc has quickly become one of the world's biggest biotech companies thanks to its Eylea treatment for macular degeneration, but its little known experimental allergy drug could become equally successful, senior company executives said in interviews.
  • Lilly stomach cancer drug prolongs life in colon cancer study

    (Reuters) - Eli Lilly and Co's LLY.N Cyramza stomach-cancer drug prolonged survival of patients with advanced colon cancer in a late-stage study, the U.S. drugmaker said on Friday. Based on favorable data from the Phase III study, Lilly said it would ask...

    Roche's rheumatoid arthritis drug wins EU approval for extended use

    ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said on Monday the European Union has approved the use of its drug RoActemra in patients with early-stage rheumatoid arthritis. Roche said the European Commission has backed RoActemra as a treatment for...

    Bristol-Myers demanda a Merck por patente de inmunoterapia en EEUU

    (Reuters) - La farmacéutica Bristol-Myers Squibb Co presentó una demanda el jueves contra Merck & Co Inc por la supuesta violación de su patente de inmunoterapia. La compañía está buscando una compensación por daños no especificada. La inmunoterapia es...

    Bristol-Myers sues Merck over U.S. immunotherapy patent

    (Reuters) - Bristol-Myers Squibb Co on Thursday filed a lawsuit against Merck & Co Inc for allegedly infringing its immunotherapy patent. The company is seeking unspecified damages. Immunotherapy is a mechanism that uses the body's own immune system to...